Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Outcomes of Tyrosine Kinase Inhibitors Immediately After Immune Checkpoint Inhibitors in Renal Cell Carcinoma.
Kato T, Nagahara A, Kawamura N, Nakata W, Soda T, Matsuzaki K, Hatano K, Kawashima A, Ujike T, Imamura R, Nishimura K, Takada S, Tsujihata M, Yamaguchi S, Takao T, Nakai Y, Nakayama M, Nonomura N, Uemura M. Kato T, et al. Among authors: yamaguchi s. Anticancer Res. 2021 Nov;41(11):5811-5816. doi: 10.21873/anticanres.15398. Anticancer Res. 2021. PMID: 34732455
The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study.
Kato T, Nagahara A, Kawamura N, Nakata W, Soda T, Matsuzaki K, Hatano K, Kawashima A, Ujike T, Imamura R, Nishimura K, Takada S, Tsujihata M, Yamaguchi S, Takao T, Nishimura K, Nonomura N, Uemura M. Kato T, et al. Among authors: yamaguchi s. Int J Clin Oncol. 2021 May;26(5):954-961. doi: 10.1007/s10147-021-01872-5. Epub 2021 Jan 20. Int J Clin Oncol. 2021. PMID: 33471290
Importance of continuing therapy and maintaining one-month relative dose intensity in sunitinib therapy for metastatic renal cell carcinoma.
Kawashima A, Tsujimura A, Takayama H, Arai Y, Nin M, Tanigawa G, Yasunaga Y, Mukai M, Uemura M, Nakai Y, Nishimura K, Nonomura N; Osaka Renal Cell Carcinoma Clinical Study Collaboration. Kawashima A, et al. Med Oncol. 2012 Dec;29(5):3298-305. doi: 10.1007/s12032-012-0236-6. Epub 2012 Apr 29. Med Oncol. 2012. PMID: 22544539
Weekly low-dose docetaxel combined with estramustine and dexamethasone for Japanese patients with metastatic castration-resistant prostate cancer.
Hatano K, Nishimura K, Nakai Y, Yoshida T, Sato M, Kawashima A, Mukai M, Nagahara A, Uemura M, Oka D, Nakayama M, Takayama H, Shimizu K, Meguro N, Tanigawa T, Yamaguchi S, Tsujimura A, Nonomura N. Hatano K, et al. Among authors: yamaguchi s. Int J Clin Oncol. 2013 Aug;18(4):704-10. doi: 10.1007/s10147-012-0429-1. Epub 2012 Jun 12. Int J Clin Oncol. 2013. PMID: 22688162 Clinical Trial.
Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.
Tomiyama E, Fujita K, Rodriguez Pena MDC, Taheri D, Banno E, Kato T, Hatano K, Kawashima A, Ujike T, Uemura M, Takao T, Yamaguchi S, Fushimi H, Yoshimura K, Uemura H, Netto GJ, Nonomura N. Tomiyama E, et al. Among authors: yamaguchi s. Int J Mol Sci. 2020 Jul 29;21(15):5390. doi: 10.3390/ijms21155390. Int J Mol Sci. 2020. PMID: 32751328 Free PMC article.
Clinical outcome and prognostic factors of sorafenib in Japanese patients with advanced renal cell carcinoma in general clinical practice.
Tanigawa G, Kawashima A, Yamaguchi S, Nishimura K, Miyoshi S, Kajikawa J, Meguro N, Yosioka T, Oka T, Hara T, Takayama H, Nonomura N; Osaka Renal Cell Carcinoma Clinical Study Collaboration. Tanigawa G, et al. Among authors: yamaguchi s. Jpn J Clin Oncol. 2011 Nov;41(11):1265-70. doi: 10.1093/jjco/hyr137. Epub 2011 Sep 29. Jpn J Clin Oncol. 2011. PMID: 21965163
Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.
Fujita K, Uemura M, Yamamoto Y, Tanigawa G, Nakata W, Sato M, Nagahara A, Kiuchi H, Nakai Y, Matsumiya K, Yamaguchi S, Nonomura N. Fujita K, et al. Among authors: yamaguchi s. Int J Clin Oncol. 2015 Feb;20(1):156-63. doi: 10.1007/s10147-014-0695-1. Epub 2014 Apr 18. Int J Clin Oncol. 2015. PMID: 24740557
5,410 results